Screening for Men

The Men's Health Screenings Worth Having — and the Ones Worth Asking For

Men are significantly less likely than women to attend routine health checks, less likely to present to their GP with symptoms, and more likely to be diagnosed with serious conditions at a later, less treatable stage. The gap in health-seeking behaviour between men and women is one of the most consistent findings in UK health data — and it contributes meaningfully to the fact that men die, on average, around four years earlier than women. Some of that gap is biological. A significant portion of it is behavioural and preventable.

The men reading this page are not the problem demographic. Health-conscious, information-seeking men in their 50s are not the ones avoiding their GP for fifteen years. But even within this group, there are specific screening conversations that don't happen as often as they should — particularly around prostate health, cardiovascular risk, and testosterone — partly because the NHS invitation system for men is notably thinner than it is for women, and partly because the PSA debate has created genuine confusion about what to ask for and when. This page tries to cut through that.

Men's Health Screenings

The Tests Men Need — and Why So Many Skip Them

Life expectancy gap

4 years

Men in the UK die on average four years earlier than women — from largely the same diseases.

The gap isn't primarily genetic. Men are significantly less likely to attend GP appointments, less likely to act on symptoms, and less likely to complete screening when invited. The four-year difference is largely a behaviour gap, not a biology gap — which means it's fixable.

Your NHS Entitlements — Free, Just Turn Up

Age 65

Aortic aneurysm scan (AAA)

A quick ultrasound that checks the main blood vessel running through your abdomen hasn't ballooned dangerously. A rupture kills within minutes. Caught early it can be monitored or repaired. One-off, automatic NHS invite — don't bin the letter.

50–74

Bowel cancer screening

A home kit arrives by post every two years. You return a small stool sample — no clinic, no appointment. Bowel cancer is the second most common cause of cancer death in men. Caught early, survival rates exceed 90%. Caught late, under 10%. Complete the kit.

40–74

NHS Health Check

Every five years — checks blood pressure, cholesterol, blood sugar and your overall risk of heart disease, stroke and diabetes. Don't wait for the letter. Ask your GP to book it. It takes 20 minutes and gives you a clear picture of where you actually stand.

Ask Your GP — These Won't Come to You

50+

PSA test (prostate)

A blood test that measures a marker raised by prostate problems — including cancer. There is no NHS prostate screening programme, which means men who want this test have to ask for it. Consider asking from age 50, or 45 if you are Black or have a close family member who had prostate cancer. The test is imperfect — discuss the limitations honestly with your GP — but not testing at all is worse.

45+

Testosterone level

Testosterone declines gradually from the mid-30s — but some men experience a steeper drop that causes fatigue, low mood, reduced muscle mass and loss of drive. This is not just "getting older." It's diagnosable and treatable. Rarely tested unless you ask. Worth knowing if several of those symptoms apply to you.

40+

Full metabolic picture — beyond standard cholesterol

Ask for ApoB and an inflammation marker alongside the standard checks. Men are at higher cardiovascular risk than women for most of adult life — and are more likely to have a heart attack without prior warning. Knowing your real numbers, not just whether they fall inside a wide normal range, is the point.

Worth Considering Privately

Heart scan (CAC score)

Detects plaque build-up in heart arteries before symptoms. Men develop coronary artery disease earlier than women — this scan gives you a concrete picture rather than a risk estimate.

Full skin check

Men are more likely to develop melanoma and significantly less likely to notice it early. A dermatologist check once in your 50s is straightforward and cheap relative to what late-stage skin cancer costs.

Hearing test

Men lose hearing earlier than women on average, often from noise exposure. Untreated hearing loss in midlife is a significant dementia risk factor. Most people wait a decade too long to address it.

Fitness test (VO2 max)

Your aerobic fitness level is the single strongest predictor of how long you'll live — stronger than cholesterol or blood pressure. A proper test gives you a number to work from and improve.

💡 The most common reason men don't get screened is that they didn't get around to it — not that they refused or were afraid. Booking the appointment is almost always the hardest part. The test itself takes minutes.

What the NHS actually offers men — and what it doesn't

The honest answer is: not much that's prostate or cancer-specific. The NHS programmes men are automatically invited to are the AAA scan at 65, the bowel cancer FIT kit from 50, and the Health Check every five years from 40. That's it. There is no NHS prostate cancer screening programme. There is no routine testosterone testing. There is no lung cancer screening that reaches most men, though targeted programmes are expanding. The invitation system for men is considerably narrower than for women, which means that building a complete picture of your health in this age group requires a more active approach.

The NHS Health Check is the most broadly useful starting point for men in the 40–74 range and the one most worth taking seriously as more than a formality. It measures blood pressure, cholesterol, BMI, blood glucose, and smoking status, and produces a ten-year cardiovascular risk score. Cardiovascular disease is the leading cause of death in men — responsible for around one in four male deaths in the UK — and the majority of heart attacks in men under 65 occur in people without a prior diagnosis. The Health Check is the mechanism for catching the precursors: elevated blood pressure, rising LDL, early insulin resistance, all of which are modifiable if caught early enough.

What to push for at that appointment: your actual QRISK3 score, not just a verbal reassurance that your numbers look fine. Your HbA1c, which indicates blood glucose regulation and pre-diabetes status. And if you have a family history of early heart disease, a specific conversation about whether a full fasting lipid panel — including lipoprotein(a) — is warranted. Lp(a) is elevated in roughly one in five people, is genetically determined, and is a significant independent cardiovascular risk factor that is not captured by the standard cholesterol test.

The AAA scan — one appointment, potentially life-saving

Abdominal aortic aneurysm screening is offered once to men at age 65: a ten-minute abdominal ultrasound that checks for dangerous enlargement of the aorta. AAA is largely silent until it ruptures — at which point survival rates are poor even with emergency surgery. The screening programme has reduced AAA-related mortality in invited men by around 50%. Men who missed their invitation, or weren't registered with a GP at the time, can self-refer directly to their local screening service without needing a GP referral first. If you're over 65 and haven't had this scan, it is worth organising today.

Bowel cancer — the kit that sits on the shelf

Bowel cancer is the second most common cause of cancer death in men in the UK. The NHS FIT kit — posted every two years to men aged 50 to 74 — detects traces of blood in the stool that may indicate polyps or early cancer, at a stage where treatment is far more likely to be curative. Uptake is lower than it should be, for reasons that are mostly about the feel of the test rather than anything more substantial. A positive result does not mean cancer — it means a colonoscopy referral to look more closely. Of those who have a colonoscopy following a positive FIT, roughly one in ten are found to have cancer. The rest have polyps, benign causes, or nothing significant. The cost of doing the test is five minutes. The cost of not doing it can be considerably higher.

Prostate cancer and the PSA conversation

Prostate cancer is the most common cancer in men in the UK — around 52,000 new diagnoses per year — and yet there is no NHS prostate cancer screening programme. The reason is not ignorance or bureaucratic failure. It is a genuinely difficult evidence problem. The PSA (prostate-specific antigen) test, the primary tool for detecting prostate cancer, is not a simple positive or negative test. It is a continuous measure with significant overlap between benign conditions — prostatitis, benign prostatic hyperplasia — and cancer. A raised PSA leads to biopsy; biopsies carry risks; and some cancers detected are slow-growing enough that they would never have caused harm if left undetected. The overdiagnosis and overtreatment problem in prostate screening is real, which is why national programmes in most countries have not been introduced.

What this means practically is nuanced. Men over 50 — and men over 45 of African-Caribbean descent, or with a father or brother diagnosed with prostate cancer — are entitled to request a PSA test from their GP under the NHS Prostate Cancer Risk Management Programme. The GP is required to discuss the benefits and limitations of the test, and then to offer it if the man still wants it. The discussion should cover what a raised result means, what the follow-up pathway looks like, and the possibility of detecting a cancer that may not need treatment. That conversation is not a reason to avoid the test — it is the reason the conversation happens before the test rather than after.

Men with a family history of prostate cancer, particularly a first-degree relative diagnosed before 60, should specifically raise this at their GP appointment. Germline BRCA2 mutations — which can be inherited from either parent — significantly elevate prostate cancer risk as well as other cancer risks, and men from families with known BRCA mutations can access genetic counselling through the NHS.

Testosterone — the conversation that often doesn't happen

Testosterone decline in men is gradual rather than abrupt — unlike the relatively sharp hormonal shift of female menopause — but by the mid-50s, a meaningful proportion of men have testosterone levels low enough to affect energy, mood, muscle mass, libido, cognitive sharpness, and sleep quality. The challenge is that these symptoms are common and non-specific, and many men attribute them to stress, age, or poor sleep rather than investigating whether a hormonal component is contributing.

Testosterone testing is not part of routine NHS screening, but a simple morning blood test — serum total testosterone — is available on NHS referral if you present with relevant symptoms. The results need to be interpreted in context: total testosterone has a wide reference range, and some men are symptomatic at levels that fall within the normal range. Free testosterone — the biologically active fraction — gives a more useful clinical picture. If your GP is dismissive of the conversation, it is reasonable to be persistent or to consider a private assessment through a men's health clinic. This is not a lifestyle optimisation question; clinically significant hypogonadism is a treatable medical condition with meaningful health consequences if left unaddressed.

Lung cancer — what's available and who qualifies

Lung cancer kills more men than any other cancer in the UK. It has no symptoms in its early stages. And it is almost entirely detectable by low-dose CT scan in higher-risk individuals — a fact that has driven the development of targeted lung health check programmes in parts of England, designed for current or former heavy smokers aged 55 to 74. These programmes are not yet universally available, but coverage is expanding. If you are or have been a significant smoker in that age range, it is worth asking your GP whether a targeted lung health check operates in your area. Private low-dose CT of the chest is available for around £200–300 and gives a meaningful picture of lung health — along with incidental findings about coronary artery calcium that have their own cardiovascular significance.

Sleep apnoea — underdiagnosed and underestimated

Obstructive sleep apnoea is significantly more common in men than women and is estimated to affect around 1.5 million men in the UK, the majority of them undiagnosed. Its consequences extend well beyond poor sleep: untreated OSA is associated with significantly elevated cardiovascular risk, cognitive impairment, elevated blood pressure, and reduced life expectancy. The classic presentation — loud snoring, witnessed breathing pauses, waking unrefreshed — is well-known, but many men normalise these symptoms for years. If your partner reports any of these signs, or if you are overweight, have a large neck circumference, or wake consistently feeling unrestored, this is worth raising with your GP. Diagnosis is via a home sleep study — a straightforward overnight monitor — and treatment with CPAP is highly effective.

'There is no NHS prostate cancer screening programme — not because of oversight, but because the PSA test is genuinely complex. Men over 50 are entitled to request it and have a proper conversation about what it means. Knowing that distinction is more useful than either ignoring it or rushing toward a test without context.'

Building your own health picture

The men's health screening landscape requires more active navigation than its women's equivalent, simply because the invitation system covers less. The practical approach is to treat your NHS Health Check as the foundation — making sure you actually attend and extract your real numbers from it — and to layer specific conversations on top of that based on your personal risk profile. Family history of prostate cancer, heart disease, or lung cancer; symptoms suggesting low testosterone or sleep apnoea; smoking history that might qualify for a lung health check — these are the threads worth pulling.

Keep your own record of key numbers: blood pressure, cholesterol, HbA1c, and any PSA results if you've had them tested. The NHS's digital health records have improved, but continuity of information across GP practices and screening programmes is still imperfect. Knowing your own data is not excessive — it is the basic infrastructure of proactive health management.